Why the study?
While intracoronary imaging (ICI) guidance is superior to angiography alone, data in all-comer acute coronary syndrome (ACS) patients remain limited.
Does intracoronary imaging-guided PCI reduce in-hospital mortality and MACCE in patients with acute coronary syndrome?
Does intracoronary imaging-guided PCI reduce in-hospital mortality and MACCE in patients with acute coronary syndrome?
In an all-comer ACS population, intracoronary imaging-guided PCI was associated with significantly lower in-hospital mortality and MACCE compared to angiography alone, particularly in left main stem and left anterior descending artery interventions.
Answers are grounded in this paper and cite their sources.
Intracoronary imaging-guided PCI was associated with lower ACS mortality and MACCE; leaves open need for randomized confirmation before practice change.
BACKGROUND: While previous studies have demonstrated the superiority of ICI-guided PCI over an angiography-based approach, there are limited data on all-comer ACS patients. This study aimed to identify the characteristics and in-hospital outcomes of patients undergoing intracoronary imaging (ICI) guided percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). METHODS: All patient undergoing PCI for ACS in England and Wales between 2006 and 2019 were retrospectively analyzed and stratified according to ICI utilization. The outcomes assessed were in-hospital all-cause mortality and major adverse cardiovascular and cerebrovascular events (MACCE) using multivariable logistic regression models. RESULTS: 598,921 patients underwent PCI for ACS, of which 41,716 (7.0 %) had ICI which was predominantly driven by IVUS use (5.6 %). ICI use steadily increased from 1.4 % in 2006 to 13.5 % in 2019. Adjusted odds of mortality (OR 0.69, 95%CI 0.58-0.83) and MACCE (OR 0.77, 95%CI 0.73-0.83) were significantly lower in the ICI group. The association between ICI and improved outcomes varied according to vessel treated with both left main stem (LMS) and LMS/left anterior descending (LAD) PCI associated with significantly lower odds of mortality (OR 0.34, 95%CI 0.27-0.44, OR 0.51 95%CI 0.45-0.56) and MACCE (OR 0.44 95%CI 0.35-0.54, OR 0.67 95%CI 0.62-0.72) respectively. CONCLUSIONS: Although ICI use has steadily increased, less than one in seven patients underwent ICI-guided PCI. The association between ICI use and improved in-hospital outcomes was mainly observed in PCI procedures involving LMS and LAD.
No takes yet. Share an insight, caveat, or question.
Zaman et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: